Prescription charge to increase 20p to £9 in April

The prescription charge in England will increase from £8.80 to £9 on April 1, the Department of Health and Social Care (DH) has confirmed.

Indpendent%20prescriber%20prescription%20pad%20.jpg
The DH said prescription charge income is expected to rise broadly in line with inflation

There will be no change to the cost of pre-paid prescription certificates (PPC), health minister Baroness Blackwood said in a statement today (February 21).

The three-month PPC will remain at £29.10, while an annual PPC will stay at £104.

“The government expects the NHS to deliver £22 billion of efficiency savings to secure the best value from NHS resources and primary care must play its part.

“This year, therefore, we have increased the prescription charge by 20p from £8.80 to £9 for each medicine or appliance dispensed,” Baroness Blackwood said.

“Taken together, this means prescription charge income is expected to rise broadly in line with inflation,” she added.

Prescription charges have increased by 20p instalments for the last three years, following a 15p rise in 2015.

Prescription cost rise “adds to NHS bill elsewhere”

In response to the DH’s announcement, Pharmaceutical Services Negotiating Committee chief executive Simon Dukes said: “Many people already find it extremely difficult to pay the prescription charge.

“While we recognise the financial pressures that the NHS is under, raising the prescription [charge] runs the risk of those most in need not getting their medicines – adding to the NHS bill elsewhere.”

Sign in or register for free

Latest from News

All the headlines: Community pharmacy funding deal

 
• By 
 • comment

Find out everything you need to know about the government’s plans for community pharmacy – as outlined in this week’s long-awaited pharmacy funding deal.

Pharmacy stop-smoking service expands to ‘non-registered’ staff

 
• By 
 • comment

The new pharmacy contract has expanded who can deliver the smoking cessation service, as well as adding the provision of two drugs via PGDs.

Revealed: 2024/25 contract cash uplift already paid

 
• By 
 • comment

Following this week’s announcement of the long-awaited pharmacy funding deal, C+D has learned that contractors have already received the additional £106 million in retrospective funding for 2024/25.

More from Politics

New evidence Brexit caused UK medicines shortages

 
• By 
 • comment

A health and social care think tank has revealed that the “elevated and troubling level” of medicine shortages in the UK can be blamed on Brexit.

Risk pharmacies ‘deprioritised’ if GP role grows, report warns

 
• By 
 • comment

A Westminster think tank has said that the government’s proposed Neighbourhood Health Service, which plans to scale up general practice, could put community pharmacies at risk of being “deprioritised”.